Annual Revenue
$234.04 M
+$101.47 M+76.55%
31 December 2023
Summary:
Revance Therapeutics annual revenue is currently $234.04 million, with the most recent change of +$101.47 million (+76.55%) on 31 December 2023. During the last 3 years, it has risen by +$156.24 million (+200.83%). RVNC annual revenue is now at all-time high.RVNC Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$59.88 M
-$5.51 M-8.43%
30 September 2024
Summary:
Revance Therapeutics quarterly revenue is currently $59.88 million, with the most recent change of -$5.51 million (-8.43%) on 30 September 2024. Over the past year, it has dropped by -$19.86 million (-24.91%). RVNC quarterly revenue is now -24.91% below its all-time high of $79.74 million, reached on 31 December 2023.RVNC Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$256.94 M
+$5.77 M+2.30%
30 September 2024
Summary:
Revance Therapeutics TTM revenue is currently $256.94 million, with the most recent change of +$5.77 million (+2.30%) on 30 September 2024. Over the past year, it has increased by +$22.91 million (+9.79%). RVNC TTM revenue is now at all-time high.RVNC TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -24.9% | +9.8% |
| 3 y3 years | +200.8% | +130.8% | +230.3% |
| 5 y5 years | +10000.0% | +10000.0% | +10000.0% |
RVNC Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +200.8% | -24.9% | +137.0% | at high | +230.3% |
| 5 y | 5 years | at high | >+9999.0% | -24.9% | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -24.9% | >+9999.0% | at high | >+9999.0% |
Revance Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $59.88 M(-8.4%) | $256.94 M(+2.3%) |
| June 2024 | - | $65.39 M(+25.9%) | $251.18 M(+4.6%) |
| Mar 2024 | - | $51.94 M(-34.9%) | $240.20 M(+2.6%) |
| Dec 2023 | $234.04 M(+76.5%) | $79.74 M(+47.4%) | $234.04 M(+14.6%) |
| Sept 2023 | - | $54.11 M(-0.6%) | $204.22 M(+14.0%) |
| June 2023 | - | $54.41 M(+18.9%) | $179.12 M(+17.0%) |
| Mar 2023 | - | $45.77 M(-8.3%) | $153.08 M(+15.5%) |
| Dec 2022 | $132.56 M(+70.4%) | $49.92 M(+72.1%) | $132.56 M(+22.1%) |
| Sept 2022 | - | $29.02 M(+2.3%) | $108.59 M(+9.3%) |
| June 2022 | - | $28.37 M(+12.3%) | $99.32 M(+10.7%) |
| Mar 2022 | - | $25.26 M(-2.7%) | $89.76 M(+15.4%) |
| Dec 2021 | $77.80 M(+407.7%) | $25.95 M(+31.4%) | $77.80 M(+23.5%) |
| Sept 2021 | - | $19.75 M(+5.0%) | $62.98 M(+33.8%) |
| June 2021 | - | $18.80 M(+41.4%) | $47.07 M(+64.8%) |
| Mar 2021 | - | $13.30 M(+19.5%) | $28.57 M(+86.4%) |
| Dec 2020 | $15.32 M(+3610.7%) | $11.13 M(+190.3%) | $15.32 M(+258.0%) |
| Sept 2020 | - | $3.83 M(+1182.6%) | $4.28 M(+770.1%) |
| June 2020 | - | $299.00 K(+415.5%) | $492.00 K(+154.9%) |
| Mar 2020 | - | $58.00 K(-34.8%) | $193.00 K(-53.3%) |
| Dec 2019 | $413.00 K(-88.9%) | $89.00 K(+93.5%) | $413.00 K(-49.1%) |
| Sept 2019 | - | $46.00 K(-83.5%) | $811.00 K(-78.7%) |
| Mar 2019 | - | $278.00 K(-42.9%) | $3.81 M(+2.3%) |
| Dec 2018 | $3.73 M | $487.00 K(-79.4%) | $3.73 M(+13.7%) |
| Sept 2018 | - | $2.36 M(+244.3%) | $3.28 M(+230.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $686.00 K(+255.4%) | $991.00 K(+160.8%) |
| Mar 2018 | - | $193.00 K(+421.6%) | $380.00 K(+45.0%) |
| Dec 2017 | $262.00 K(-12.7%) | $37.00 K(-50.7%) | $262.00 K(-12.7%) |
| Sept 2017 | - | $75.00 K(0.0%) | $300.00 K(0.0%) |
| June 2017 | - | $75.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 2017 | - | $75.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 2016 | $300.00 K(0.0%) | $75.00 K(0.0%) | $300.00 K(0.0%) |
| Sept 2016 | - | $75.00 K(0.0%) | $300.00 K(0.0%) |
| June 2016 | - | $75.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 2016 | - | $75.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 2015 | $300.00 K(-21.7%) | $75.00 K(0.0%) | $300.00 K(0.0%) |
| Sept 2015 | - | $75.00 K(0.0%) | $300.00 K(0.0%) |
| June 2015 | - | $75.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 2015 | - | $75.00 K(0.0%) | $300.00 K(-21.7%) |
| Dec 2014 | $383.00 K(-37.9%) | $75.00 K(0.0%) | $383.00 K(-37.9%) |
| Sept 2014 | - | $75.00 K(0.0%) | $617.00 K(-11.9%) |
| June 2014 | - | $75.00 K(-52.5%) | $700.00 K(0.0%) |
| Mar 2014 | - | $158.00 K(-48.9%) | $700.00 K(+13.5%) |
| Dec 2013 | $617.00 K(-13.9%) | $309.00 K(+95.6%) | $617.00 K(+45.2%) |
| Sept 2013 | - | $158.00 K(+110.7%) | $425.00 K(+59.2%) |
| June 2013 | - | $75.00 K(0.0%) | $267.00 K(+39.1%) |
| Mar 2013 | - | $75.00 K(-35.9%) | $192.00 K(+64.1%) |
| Dec 2012 | $717.00 K(+28.7%) | $117.00 K | $117.00 K |
| Dec 2011 | $557.00 K | - | - |
FAQ
- What is Revance Therapeutics annual revenue?
- What is the all time high annual revenue for Revance Therapeutics?
- What is Revance Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Revance Therapeutics?
- What is Revance Therapeutics quarterly revenue year-on-year change?
- What is Revance Therapeutics TTM revenue?
- What is the all time high TTM revenue for Revance Therapeutics?
- What is Revance Therapeutics TTM revenue year-on-year change?
What is Revance Therapeutics annual revenue?
The current annual revenue of RVNC is $234.04 M
What is the all time high annual revenue for Revance Therapeutics?
Revance Therapeutics all-time high annual revenue is $234.04 M
What is Revance Therapeutics quarterly revenue?
The current quarterly revenue of RVNC is $59.88 M
What is the all time high quarterly revenue for Revance Therapeutics?
Revance Therapeutics all-time high quarterly revenue is $79.74 M
What is Revance Therapeutics quarterly revenue year-on-year change?
Over the past year, RVNC quarterly revenue has changed by -$19.86 M (-24.91%)
What is Revance Therapeutics TTM revenue?
The current TTM revenue of RVNC is $256.94 M
What is the all time high TTM revenue for Revance Therapeutics?
Revance Therapeutics all-time high TTM revenue is $256.94 M
What is Revance Therapeutics TTM revenue year-on-year change?
Over the past year, RVNC TTM revenue has changed by +$22.91 M (+9.79%)